Cancer Institute And Hospital, Chinese Academy Of Medical Sciences

This study is testing whether adding a newer immunotherapy drug called glofitamab to two existing chemotherapy drugs (gemcitabine and oxaliplatin) can help patients with a specific type of aggressive lymphoma that hasn't responded well to initial treatment. The trial will enroll …

This study is testing whether adding a more affordable immunotherapy drug called Toripalimab to standard chemoradiotherapy can better control high-risk, locally advanced cervical cancer. It will involve about 130 patients in China who have not had prior treatment. The main goal i…

This study is testing a three-drug combination called XTD for adults with Langerhans cell histiocytosis (LCH) that has come back or hasn't responded to other treatments. The goal is to see if this combination can control the disease and keep it from getting worse. Researchers wil…

This large study is testing whether adding radiation to a specific set of lymph nodes inside the chest wall helps prevent breast cancer from coming back in high-risk patients. It involves 2,400 people who have already had surgery and chemotherapy. Researchers will compare two rad…

This study is testing a new combination of drugs for people with a type of blood cancer called marginal zone lymphoma who have not yet received treatment. The goal is to see if this regimen can effectively control the disease while causing fewer severe side effects than current s…

This study looks back at 300 patients with advanced stomach or gastroesophageal junction cancer who received treatment before and after surgery. Researchers are analyzing which treatment approaches led to the best long-term survival and whether tumor response to pre-surgery treat…

This study is testing whether adding an immunotherapy drug called toripalimab to standard chemotherapy and radiation works better for people with large, advanced non-small cell lung cancer that cannot be removed by surgery. The goal is to see if this combination can better contro…

This study is testing whether a shorter, more targeted radiation treatment can effectively prevent cancer from returning in early-stage breast cancer patients. The treatment delivers radiation only to the area where the tumor was removed, over just two weeks instead of the typica…

This study is testing a new artificial intelligence (AI) tool designed to predict a specific cancer marker called HER2 in bladder cancer. The AI analyzes a patient's existing MRI scans and digital pathology images to see if it can accurately determine HER2 status, which helps gui…

This study is testing whether tracking lymphoma DNA in blood can help predict how well treatment is working. Researchers will collect blood samples from 60 lymphoma patients before, during, and after treatment to see if changes in this DNA match up with scan results and long-term…

This study looks back at the medical records of 10,000 lung cancer patients who received immunotherapy before surgery. Researchers want to understand which follow-up treatments after surgery lead to the best survival rates and identify markers that predict which patients need add…